Angola has launched one of the largest public health campaigns in its history, focusing on vaccination against Human Papillomavirus (HPV), the main cause of cervical cancer. The campaign aims to protect more than two million girls aged 9 to 12 across the country between October 27 and November 7.
Cervical cancer is a leading cause of death among women of reproductive age in Angola, yet it is preventable. According to WHO estimates, more than 2,000 new cases occur each year, with approximately half resulting in death. The HPV vaccine is safe, effective, and recommended by WHO, providing protection against the most common virus types that cause cervical cancer. Each dose administered is considered a vital step toward preventing a disease that should not claim lives.
To ensure broad coverage, 1,667 teams from the Expanded Program on Immunization are visiting public and private schools, health facilities, and communities, aiming for at least 70% of eligible girls to receive the vaccine free of charge. The vaccine is administered in a single dose, following WHO guidelines.
This campaign positions Angola at the forefront of the Global Strategy for the Elimination of Cervical Cancer, aligning with Sustainable Development Goals and Universal Health Coverage. Dr. Tomás Valdez, WHO Acting Representative, emphasized that each dose represents a victory against the disease, an investment in the future, and protection for Angolan families.
The official launch of the campaign took place in Namibe province, where Diego Zorrilla, Acting UN Resident Coordinator, highlighted the historic nature of Angola’s step to protect its girls and ensure a healthier future.
Vaccination against cervical cancer in Angola is the result of 16 years of preparation and mobilization, involving national authorities, health partners, civil society, and the private sector. Health Minister Dr. Sílvia Lutucuta described it as an unprecedented joint effort in the country’s public health history, marking the realization of a long-term goal to protect young Angolan women.
The campaign is championed by the First Lady, Dr. Ana Dias Lourenço, who serves as the national ambassador, mobilizing institutions, community leaders, and the public to ensure no girl is left behind.
HPV vaccination is part of WHO’s global strategy to eliminate cervical cancer as a public health problem by 2030. The strategy aims for 90% of girls to be vaccinated before age 15, 70% of women to undergo regular screening, and 90% of diagnosed women to receive appropriate treatment.
The operation is led by the Ministries of Health and Education with technical and logistical support from WHO, UNICEF, UNDP, GAVI, the European Union, the European Investment Bank, and other strategic partners. WHO has supported Angola in conducting socio-behavioral studies on vaccine acceptance, developing communication and community engagement strategies, and preparing microplans, manuals, and guidance documents to ensure effective implementation.
The mission is now clear: inform, mobilize, and act to vaccinate all eligible girls across Angola. WHO urges parents, teachers, community leaders, journalists, and influencers to spread accurate information and encourage participation in the vaccination campaign.
